Satyen K. Bordoloi My first memory of cancer is the younger brother of a classmate. Blood cancer, we whispered between ...

For a decade after its discovery, CRISPR gene editing was stuck on the cusp of transforming medicine. Then, in 2023, scientists started using it on sickle-cell disease, and Victoria Gray, a patient ...

We're living in a moment where science fiction is becoming medical reality. Imagine a world where doctors can simply rewrite ...

On the roads, motor-vehicle deaths — which spiked during the pandemic — have now fallen for several years in a row: the ...

As of Tuesday, December 23, Editas Medicine, Inc.’s EDIT share price has dipped by 5.08%, which has investors questioning if this is right time to buy.

Cambodia border conflict, and the AI race are among the 10 prominent international events in 2025 as selected by the Vietnam News Agency.

Gene editing has the potential to cure thousands of people suffering from devastating rare diseases. But the Nobel Prize-winning technology faces a basic math problem: It’s not profitable to spend ...

He was cast as a real-life Dr Frankenstein, a scientist whose ego had led him to tamper with human life. After more than a hundred Chinese scientists issued a statement condemning his experiment, ...

Crispr Therapeutics AG remains a Strong Buy, driven by forthcoming revenue following Casgevy's FDA/EMA approvals and a robust, expanding pipeline targeting high-value indications. CRSP's commercial ...

Worsham and Jena are physicians and researchers at Harvard Medical School and the authors of “Random Acts of Medicine: The Hidden Forces That Sway Doctors, Impact Patients and Shape Our Health.” This ...

Chinese scientists have genetically tweaked a fungus to make protein-rich “meat”, which they say can be a low-cost, environmentally friendly alternative to chicken.

Rapid innovation, expanding clinical pipelines, and rising demand for curative treatments position gene therapy as a ...